Clinical Trial Update: Rapamycin In Angiomyolipomas In Patients With Tuberous Sclerosis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on rapamycin (sirolimus) for angiomyolipomas in patients with tuberous sclerosis; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angiomyolipoma
• Tuberous Sclerosis Complex

Drugs mentioned

• Rapamycin (sirolimus)

Snippet

Sponsor: Fundacio Puigvert | Conditions: Angiomyolipoma | Phase 4 | Status: COMPLETED